Boston Trust Walden Corp Has $9 Million Holdings in AMETEK, Inc. $AME

Boston Trust Walden Corp cut its holdings in AMETEK, Inc. (NYSE:AMEFree Report) by 5.4% in the first quarter, HoldingsChannel reports. The firm owned 42,000 shares of the technology company’s stock after selling 2,410 shares during the period. Boston Trust Walden Corp’s holdings in AMETEK were worth $9,003,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Darwin Wealth Management LLC bought a new position in shares of AMETEK in the second quarter worth about $25,000. CoreCap Advisors LLC grew its stake in shares of AMETEK by 84.3% during the fourth quarter. CoreCap Advisors LLC now owns 129 shares of the technology company’s stock valued at $26,000 after purchasing an additional 59 shares during the last quarter. MV Capital Management Inc. bought a new stake in shares of AMETEK during the fourth quarter valued at approximately $28,000. Brown Lisle Cummings Inc. increased its holdings in shares of AMETEK by 878.6% in the first quarter. Brown Lisle Cummings Inc. now owns 137 shares of the technology company’s stock valued at $29,000 after purchasing an additional 123 shares in the last quarter. Finally, BOKF NA raised its position in AMETEK by 137.7% in the 4th quarter. BOKF NA now owns 145 shares of the technology company’s stock worth $30,000 after purchasing an additional 84 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.

AMETEK Trading Up 0.0%

Shares of AME stock opened at $234.66 on Friday. AMETEK, Inc. has a 12-month low of $174.43 and a 12-month high of $244.71. The company has a market capitalization of $53.78 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 3.29 and a beta of 0.99. The firm has a 50 day moving average price of $231.05 and a two-hundred day moving average price of $224.36. The company has a quick ratio of 0.72, a current ratio of 1.14 and a debt-to-equity ratio of 0.10.

AMETEK (NYSE:AMEGet Free Report) last announced its earnings results on Thursday, April 30th. The technology company reported $1.97 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.07. The company had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.91 billion. AMETEK had a return on equity of 16.63% and a net margin of 20.11%.The firm’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.75 earnings per share. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. As a group, analysts predict that AMETEK, Inc. will post 8.13 earnings per share for the current year.

AMETEK Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th were given a dividend of $0.34 per share. The ex-dividend date was Monday, June 15th. This represents a $1.36 annualized dividend and a yield of 0.6%. AMETEK’s dividend payout ratio (DPR) is presently 20.54%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on AME shares. Mizuho set a $270.00 price objective on AMETEK in a research report on Friday, May 1st. Royal Bank Of Canada boosted their target price on AMETEK from $259.00 to $260.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Truist Financial upped their price target on AMETEK from $275.00 to $303.00 and gave the company a “buy” rating in a research note on Thursday. Rothschild & Co Redburn set a $265.00 price target on AMETEK in a report on Thursday, June 18th. Finally, BMO Capital Markets initiated coverage on AMETEK in a research report on Friday, March 27th. They issued an “outperform” rating and a $253.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, AMETEK currently has a consensus rating of “Moderate Buy” and a consensus target price of $255.57.

View Our Latest Stock Analysis on AMETEK

AMETEK Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Stories

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.